Ireland
  • Europe
  • Headlines
  • Ireland
  • World
  • Business
  • Technology
  • Entertainment
  • Sports
  • Science
  • Health

Categories

  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Computing
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Gadgets
  • Genetics
  • Headlines
  • Health
  • Healthcare
  • Internet
  • Ireland
  • Jobs
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • Nutrition
  • Personal finance
  • Physics
  • Science
  • Space
  • Sports
  • Technology
  • TV
  • Virtual reality
  • Wildlife
  • World
Ireland
  • Europe
  • Headlines
  • Ireland
  • World
  • Business
  • Technology
  • Entertainment
  • Sports
  • Science
  • Health

Browsing Tag

cardiovascular events

4 posts
NNutrition
Yahoo news home
Read More

Scientists Just Discovered a Surprising Health Risk of a High-Protein Diet

  • November 22, 2025
Reviewed by Dietitian Emily Lachtrupp, M.S., RD Design elements: Getty Images. EatingWell design. Key Points A new study…
HHealth
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy | Cardiovascular Diabetology
Read More

Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy | Cardiovascular Diabetology

  • November 21, 2025
Amiel SA. The consequences of hypoglycaemia. Diabetologia. 2021;64(5):963–70. https://doi.org/10.1007/s00125-020-05366-3. Article  CAS  PubMed  PubMed Central  Google Scholar  American Diabetes…
MMedication
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results?
Read More

How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?

  • October 23, 2025
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
MMedication
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
Read More

Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis

  • August 18, 2025
“Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…
Ireland
www.europesays.com